🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial teste...
Status
Completed
Location
Multiple Locations
Start Date
1997-09-27
Trial ID
NCT06395194
Treatments Being Tested
This randomized controlled clinical study aims to evaluate the effect of Mo...
Status
Completed
Location
The First Affiliated Hospital of Heilongjiang University of Chinese Medicine
Start Date
2023-10-01
Trial ID
NCT07702669
Treatments Being Tested
The primary objective of this study is to demonstrate that in patients with...
Status
Completed
Location
Ziekenhuis Oost Limburg
Start Date
2014-07
Trial ID
NCT02200822
Treatments Being Tested
Obesity is a complex metabolic state at which many pathophysiological pathw...
Status
Completed
Location
Hypertension Unit, First Cardiology Clinic, Hippocration General Hospital, University of Athens, Athens, Greece
Start Date
2018-09-01
Trial ID
NCT03476616
Treatments Being Tested
Hypertension is a major global health problem, affecting about 30% of peopl...
Status
Completed
Location
Department of Cardiology
Start Date
2025-11-01
Trial ID
NCT07544888
Treatments Being Tested
In patients with heart failure due to a reversible underlying cause-such as...
Status
Recruiting
Location
Keimyung University Dongsan Hospital
Start Date
2026-05-20
Trial ID
NCT07572032
Treatments Being Tested
This study will assess the efficacy of an intensive blood pressure manageme...
Status
Completed
Location
Novartis Pharmaceuticals
Start Date
2009-07
Trial ID
NCT00902304
The purpose of the study is to evaluate how well tolerated and effective an...
Status
Recruiting
Location
Cleveland Clinic
Start Date
2019-11-08
Trial ID
NCT04191681
Treatments Being Tested
The purpose of this study is to demonstrate the superiority of LCZ696 over ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2017-08-22
Trial ID
NCT03066804